BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 35027386)

  • 1. Unusual presentation of cornea verticillata with intravitreal methotrexate in a case of primary intraocular lymphoma.
    Hasan N; Narde HK; Das AK; Chawla R
    BMJ Case Rep; 2022 Jan; 15(1):. PubMed ID: 35027386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corneal epithelial toxicity with intravitreal methotrexate in a case of B-cell lymphoma with ocular involvement.
    Sahay P; Maharana PK; Temkar S; Chawla R
    BMJ Case Rep; 2018 Aug; 2018():. PubMed ID: 30150351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A case of intraocular lymphoma having retinal adverse events associated with intravitreal methotrexate].
    Kuroiwa N; Abematsu N; Matsuo Y; Nakao K; Sakamoto T
    Nippon Ganka Gakkai Zasshi; 2011 Jul; 115(7):611-6. PubMed ID: 21815491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic vitrectomy for vitreal recurrence of intraocular lymphoma resistant to intravitreal methotrexate post systemic chemotherapy.
    Venkatesh P; Gogia V; Khanduja S; Gupta S; Kumar L; Garg S
    J Cancer Res Ther; 2015; 11(3):668. PubMed ID: 26458712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of primary intraocular lymphoma treated by intravitreal methotrexate.
    Kim E; Kim C; Lee J; Cho Y
    Korean J Ophthalmol; 2009 Sep; 23(3):210-4. PubMed ID: 19794951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxic corneal epitheliopathy after intravitreal methotrexate and its treatment with oral folic acid.
    Gorovoy I; Prechanond T; Abia M; Afshar AR; Stewart JM
    Cornea; 2013 Aug; 32(8):1171-3. PubMed ID: 23676783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Characteristics of Primary Vitreoretinal Lymphoma in an Indian Population.
    Mahajan S; Nijhawan R; Rajwanshi A; Karkhur S; Mulkutar S; Dogra M; Lal V; Gupta V; Gupta A
    Ocul Immunol Inflamm; 2017 Oct; 25(5):633-638. PubMed ID: 27003620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of intravitreal methotrexate in the management of primary central nervous system lymphoma with ocular involvement.
    Smith JR; Rosenbaum JT; Wilson DJ; Doolittle ND; Siegal T; Neuwelt EA; Pe'er J
    Ophthalmology; 2002 Sep; 109(9):1709-16. PubMed ID: 12208721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraocular T-cell Lymphoma: Clinical Presentation, Diagnosis, Treatment, and Outcome.
    Chaput F; Amer R; Baglivo E; Touitou V; Kozyreff A; Bron D; Bodaghi B; LeHoang P; Bergstrom C; Grossniklaus HE; Chan CC; Pe'er J; Caspers LE
    Ocul Immunol Inflamm; 2017 Oct; 25(5):639-648. PubMed ID: 27002464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced frequency of Intravitreal methotrexate injection lowers the risk of Keratopathy in Vitreoretinal lymphoma patients.
    Zhou X; Zhou X; Shi H; Lai J; Wang Q; Li Y; Chen K; Li Q; Zhou Q; Cao X; Chen B; Xiao J
    BMC Ophthalmol; 2020 May; 20(1):189. PubMed ID: 32397978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of intravitreal methotrexate for vitreo-retinal lymphoma - 20 years of experience.
    Habot-Wilner Z; Frenkel S; Pe'er J
    Br J Haematol; 2021 Jul; 194(1):92-100. PubMed ID: 33900619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of intravitreal methotrexate to salvage eyes with relapsed primary intraocular lymphoma.
    Mohammad M; Andrews RM; Plowman PN; Hay G; Arora AK; Cohen VML; Sagoo MS
    Br J Ophthalmol; 2022 Jan; 106(1):135-140. PubMed ID: 33087316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eyewash with balanced salt solution after intravitreal methotrexate injection in a case of vitreoretinal lymphoma: a simple but effective way to prevent ocular surface toxicity.
    Moharana B; Parija S; Palanisamy S; Mishra P
    BMJ Case Rep; 2023 Jul; 16(7):. PubMed ID: 37474142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraocular Metastasis of Large T-cell Lymphoma Transformed from Mycosis Fungoides.
    Chen D; Modi Y; Goduni L; Chong J; Tsui E; Breazzano MP; Dedania V; Marr B; Sarraf D
    Ocul Immunol Inflamm; 2023 Apr; 31(3):585-588. PubMed ID: 35201959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Asian patient with intraocular lymphoma treated by intravitreal methotrexate.
    Wang JK; Yang CM; Lin CP; Shan YD; Lo AY; Tien HF
    Jpn J Ophthalmol; 2006; 50(5):474-478. PubMed ID: 17013703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curious case of bilateral non-resolving vitritis - Unmasking the masquerade on ultra-widefield imaging.
    Delhiwala K
    Indian J Ophthalmol; 2022 Apr; 70(4):1438-1439. PubMed ID: 35326082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and toxicity of intravitreal chemotherapy for primary intraocular lymphoma.
    Velez G; Yuan P; Sung C; Tansey G; Reed GF; Chan CC; Nussenblatt RB; Robinson MR
    Arch Ophthalmol; 2001 Oct; 119(10):1518-24. PubMed ID: 11594954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravitreal methotrexate for treating vitreoretinal lymphoma: 10 years of experience.
    Frenkel S; Hendler K; Siegal T; Shalom E; Pe'er J
    Br J Ophthalmol; 2008 Mar; 92(3):383-8. PubMed ID: 18303160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two cases of primary intraocular lymphoma: fine needle aspiration diagnosis and intravitreal methotrexate treatment.
    Zhao T; Li Y; Tang L; Wei X; Zhu X
    J Huazhong Univ Sci Technolog Med Sci; 2011 Feb; 31(1):142-144. PubMed ID: 21336740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraocular chemotherapy for vitreoretinal lymphoma: A review.
    Kvopka M; Lake SR; Smith JR
    Clin Exp Ophthalmol; 2020 Mar; 48(2):240-248. PubMed ID: 31680408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.